Pelvic floor and faecal incontinence treatmentemerging
1 project
AMELIE project (2020-2026) focuses on anchored muscle cells for incontinence, targeting obstetric trauma and anal sphincter repair.
Organization
CENTRE HOSPITALIER ROUEN
French university hospital contributing clinical expertise in cardiac devices, dementia care, and regenerative therapies for pelvic floor disorders.
University hospitalhealthFRThin data (2/5)
H2020 projects
3
As coordinator
0
Total EC funding
€1.2M
Unique partners
22
What they do
Their core work
Centre Hospitalier Rouen (Hôpital Charles Nicolle) is a major public university hospital in Normandy, France, serving as both a clinical care provider and a clinical research site. In H2020, they contributed clinical expertise in areas spanning dementia patient care, cardiac device technology, and pelvic floor disorders including faecal incontinence. Their role in EU projects is that of a clinical partner — providing patient access, medical know-how, and real-world validation for health technologies developed by research-driven consortia.
Core expertise
What they specialise in
Dementia care and patient self-managementsecondary
1 project
CAREGIVERSPRO-MMD (2016-2019) developed self-management interventions and community services for dementia patients and caregivers.
Cardiac medical devices — clinical validationsecondary
1 project
AXONE (2017-2020) advanced commercial multiple electrode lead technology for cardiac disease treatment.
3 projects
Across all three projects, the hospital consistently serves as a clinical partner providing patient cohorts and medical expertise for health technology validation.
Evolution & trajectory
How they've shifted over time
Early focus
Digital health and cardiac devices
Recent focus
Regenerative medicine for incontinence
With only three projects spanning 2016–2026, evolution is modest but detectable. Early participation (2016–2019) centred on digital health and chronic disease management — dementia caregiving tools and cardiac device development. The most recent project (AMELIE, 2020–2026) marks a shift toward regenerative medicine and tissue engineering for surgical conditions like faecal incontinence, suggesting growing involvement in advanced therapy medicinal products (ATMPs).
Moving from digital/device-based health solutions toward cell therapy and regenerative medicine, which could make them a valuable clinical partner for ATMP developers seeking hospital-based trial sites.
Collaboration profile
How they like to work
Role: specialist_contributorReach: European10 countries collaborated
Centre Hospitalier Rouen participates exclusively as a consortium partner — never as coordinator — which is typical for hospitals contributing clinical expertise rather than driving research agendas. With 22 unique partners across 10 countries in just 3 projects, they join relatively large, internationally diverse consortia. This suggests they are approachable partners comfortable working within multi-national teams, though they are not a networking hub themselves.
Collaborated with 22 distinct partners across 10 countries in three projects, indicating broad European reach for a hospital with limited H2020 activity. No visible geographic concentration — partnerships span multiple EU member states.
Why partner with them
What sets them apart
As a large public university hospital in Rouen, they offer something many research institutions cannot: direct access to patient populations and clinical infrastructure for health technology validation. Their involvement in AMELIE positions them among the few French hospitals with hands-on experience in cell-based incontinence therapies — a niche but growing clinical field. For consortium builders, they represent a reliable French clinical site with experience across multiple therapeutic areas.
Notable projects
Highlights from their portfolio
- AMELIEMost recent and longest-running project (2020-2026), exploring an advanced cell therapy approach for faecal incontinence — a distinctive clinical niche.
- CAREGIVERSPRO-MMDLargest EC contribution (EUR 689,875) and focused on dementia caregiver support — a high-societal-impact topic with strong policy relevance.
Cross-sector capabilities
Digital health and patient self-management platformsMedical device clinical validationRegenerative medicine and cell therapyElderly care and social innovation
More in Health & Biomedical
See all Health & Biomedical organizations →KOBENHAVNS UNIVERSITET
Denmark's largest research university, excelling in genomics, CRISPR, microbiome science, ancient DNA, and climate research across 696 H2020 projects.
Open →
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France's national biomedical research agency — 400+ H2020 projects spanning neuroscience, infectious disease, cancer, and omics-driven diagnostics.
Open →
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Germany's leading research university in molecular biosciences and translational medicine, with 303 H2020 projects and exceptional ERC grant concentration.
Open →